MIRA INFORM REPORT

 

 

Report Date :

18.10.2014

 

IDENTIFICATION DETAILS

 

Name :

ANZCHEM PTY LIMITED

 

 

Registered Office :

Building A, Level 1 11 Talavera Road North Ryde New South Wales 2113

 

 

Country :

Australia

 

 

Financials (as on) :

31.08.2013

 

 

Date of Incorporation :

30.12.2002

 

 

Com. Reg. No.:

103260215

 

 

Legal Form :

Australian Proprietary Company, Limited by Shares

 

 

Line of Business :

Import & distribution of pharmaceutical, veterinary, nutraceutical and food ingredients products.

 

 

No. of Employees :

20

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Australia

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

AUSTRALIA - ECONOMIC OVERVIEW

 

The Australian economy has experienced continuous growth and features low unemployment, contained inflation, very low public debt, and a strong and stable financial system. By 2012, Australia had experienced more than 20 years of continued economic growth, averaging 3.5% a year. Demand for resources and energy from Asia and especially China has grown rapidly, creating a channel for resources investments and growth in commodity exports. The high Australian dollar has hurt the manufacturing sector, while the services sector is the largest part of the Australian economy, accounting for about 70% of GDP and 75% of jobs. Australia was comparatively unaffected by the global financial crisis as the banking system has remained strong and inflation is under control. Australia has benefited from a dramatic surge in its terms of trade in recent years, stemming from rising global commodity prices. Australia is a significant exporter of natural resources, energy, and food. Australia's abundant and diverse natural resources attract high levels of foreign investment and include extensive reserves of coal, iron, copper, gold, natural gas, uranium, and renewable energy sources. A series of major investments, such as the US$40 billion Gorgon Liquid Natural Gas project, will significantly expand the resources sector. Australia is an open market with minimal restrictions on imports of goods and services. The process of opening up has increased productivity, stimulated growth, and made the economy more flexible and dynamic. Australia plays an active role in the World Trade Organization, APEC, the G20, and other trade forums. Australia has bilateral free trade agreements (FTAs) with Chile, Malaysia, New Zealand, Singapore, Thailand, and the US, has a regional FTA with ASEAN and New Zealand, is negotiating agreements with China, India, Indonesia, Japan, and the Republic of Korea, as well as with its Pacific neighbors and the Gulf Cooperation Council countries, and is also working on the Trans-Pacific Partnership Agreement with Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, Singapore, the US, and Vietnam

 

Source : CIA


Company name and address

 

ANZCHEM PTY LIMITED

CORPORATE DETAILS

 

Verified Address

 

Subject name
ANZCHEM PTY LIMITED
Business address

1 Braidwood Street
Town

Enfield
Province

New South Wales
Zip / Postal code

2136
Country

Australia
Telephone

+61 2 94752200
Fax

+61 2 94752211
Email

info@anzchem.com.au
Website

www.anzchem.com.au

 

Registered address
Building A, Level 1
11 Talavera Road

Town

North Ryde
Province

New South Wales
Zip / Postal code

2113
Country

Australia
Postal address

P.O. BOX 5264
Town

Chullora
Province

New South Wales
Zip / Postal code

2190
Country

Australia

 

SUMMARY DETAILS

 

Report Summary

 

Date registered
30/12/2002
Legal form

Australian Proprietary Company, Limited by Shares
Key personnel

Manjit Singh
Line of business

The Subject’s business consist of import & distribution of pharmaceutical, veterinary, nutraceutical and food ingredients products.

Staff employed

20 employees (Subject); 113,000 employees (Associated British Foods Group)

Paid-up capital
AUD 50,000.00
Sales turnover / Revenue / Income

AUD 16,856,206.00 (Non-Consolidated 12 months, 31/08/2013)
Net income / loss

AUD 1,290,709.00 (Non-Consolidated 12 months, 31/08/2013)
Total assets

AUD 11,104,167.00 (Non-Consolidated 12 months, 31/08/2013)
Share equity

AUD 7,869,464.00 (Non-Consolidated 12 months, 31/08/2013)

 

Subject’s Credit Risk Analysis

 

Country risk
Country risk is minimal
Operation trend

Operational trend is steady
Management experience

Management is adequately experienced
Financial performance

Financial performance is fair

 

Organisation structure
Organisational structure is stable
Detrimental

No detrimental found
Payment history

No payment delays noted
Credit amount requested

Not described.

 

STATUTORY DETAILS

 

Registry Information

 

Date registered
30/12/2002
Legal form

Australian Proprietary Company, Limited by Shares
Registration number

Australian Company Number: 103260215
Registered authority

Australian Securities and Investments Commission
Tax / VAT number

Australian Business Number: 27103260215

 

Statutory status
Active
Previous name

NEW ABF COMPANY PTY LTD (initial)
Change of legal form

None reported.
Other registration

ANZCHEM is a business name owned by the Subject registered on 18/10/2004 under business registration numbers: B1791574M and BN98095817.

 

 

BOARD OF MANAGEMENT

 

Key Personnel

 

Name
Manjit Singh
Designation

Managing Director

 

 

 


BOARD OF DIRECTORS

 

Appointments

 

Name
Shuvasis Rana Kayal
Title

Director
Appointment date

21/01/03
Address

917 Winding Lane
Media, PA 19103
United States Of America

Biography

Born on 07-02-1961 in Calcutta, India.
Name

Manjit Singh
Title

Director
Appointment date

30/10/07
Address

7A Bernard Place
Cherrybrook, NSW 2126
Australia

Biography

Born on 27-03-1955 in Mombassa, Kenya.
Name

Chrysanthus Ballarmine Fernando
Title

Director
Appointment date

18/08/14
Address

88 Highs Road
West Pennant Hills, NSW 2125
Australia
Biography

Born on 13-05-1952 in Colombo, Sri Lanka.
Name

Andrew Gerard Frank Cullen
Title

Director and Company Secretary
Appointment date

26/02/13
Address

43 Darnley Street
Gordon, NSW 2072
Australia


Biography

Born on 17-10-1970 in London, United Kingdom.

 

Staff employed
20 employees (Subject); 113,000 employees (Associated British Foods Group)

 

Other Appointments

 

Auditor
KPMG
10 Shelley Street
Sydney, NSW 2000
Australia

 

 

 

SHARE CAPITAL

 

Composition

 

Authorized capital
AUD50,000.00
Number / Type of shares

50,000 Ordinary Shares
Share par value

AUD1.00
Issued capital

AUD50,000.00

Paid-up capital
AUD50,000.00

 

 

OWNERSHIP / SHAREHOLDERS

 

Composition

 

Shareholder name
SPI PHARMA INC
Address

321 Cherry Lane
New Castle De 19720
United States of America
Number / Type of shares

50,000 Ordinary Shares
Percentage (%) of shares

100%

 

 

CORPORATE AFFILIATIONS AND RELATED COMPANIES

 

Structure

 

Company name
GARFIELD WESTON FOUNDATION
Affiliation type

Ultimate Holding Company
Country of business

United Kingdom
Comments

The W. Garfield Weston Foundation is a private Canadian family foundation, established in the 1950's by Willard Garfield Weston and his wife Reta. In 1924 Garfield inherited his father's company and during his life established bakeries and other successful enterprises throughout Canada and in many parts of the world. Today, these businesses include the George Weston Limited and Loblaw Companies Limited, companies in food retailing, processing and distribution. The founders believed that as the funds are generated through the hard work and success of these Canadian companies, grants should be given in Canada for the benefit of Canadians. For three generations, the W. Garfield Weston Foundation
has maintained a family tradition of supporting charitable organizations across
Canada. Today the Foundation directs the majority of its funds to projects in the fields of land conservation, education, and science in Canada's North.

Company name

WITTINGTON INVESTMENTS LIMITED
Affiliation type

Superior Holding Company
Country of business

United Kingdom

Comments

Wittington Investments Limited is a holding company, which through its subsidiaries processes and distributes food products. The company's subsidiaries also operate furniture and furnishing stores. Wittington Investments Limited was incorporated in 1941 and is based in London, United Kingdom. The company
operates as a subsidiary of Garfield Weston Foundation.

Wittington Investments Limited is an unquoted British investment company. It is
79.2% owned by the Garfield Weston Foundation, which is one of the UK's largest grant-making trusts, and 20.8% owned by members of the Weston family. Wittington Investments owns 54.5% of Associated British Foods, which is one of
the largest food companies in the world, and is itself the parent company of Primark, the largest discount clothing chain in the UK and Ireland. Wittington Investments also owns London department store Fortnum & Mason and Heal's, a
UK chain of homeware and furnishing department stores, It also owns De Bijenkorf an upscale department store in Holland. Associated British Foods also own British Sugar processor of all of the UK beet crop and producer of half the
UK consumption of sugar.

Company name

ASSOCIATED BRITISH FOODS PLC
Affiliation type

Intermediate Holding Company
Country of business

United Kingdom
Comments

Associated British Foods plc operates as a diversified food, ingredients, and retail group worldwide. The company operates through five segments: Grocery, Sugar, Agriculture, Ingredients, and Retail. The Grocery segment manufactures and sells grocery products, including hot beverages, sugar and sweeteners, vegetable oils,
bread and baked goods, cereals, ethnic foods, herbs and spices, and meat products to retail, wholesale, and foodservice businesses. The Sugar segment
engages in growing and processing sugar beet and sugar cane for sale to industrial users. The Agriculture segment manufactures animal feeds and other products for the agriculture sector, as well as offers technology and services to the food, drink, and animal feed sectors. The Ingredients segment manufactures bakers’ yeast, bakery ingredients, specialty proteins, enzymes, lipids, and yeast extracts. The Retail segment is involved in buying and merchandising clothing and accessories through the Primark and Penneys retail chains, which offer
womenswear, lingerie, childrenswear, menswear, footwear, accessories, hosiery,
and homeware. The company was founded in 1935 and is based in London, the United Kingdom. Associated British Foods plc is a subsidiary of Wittington
Investments Limited.

Company name

SPI PHARMA, INC.
Affiliation type

Parent Company
Country of business

United States of America

Comments

SPI Pharma, Inc. provides custom formulation solutions for pharmaceutical and
neutriceutical, and animal health markets. The company offers excipients, including effervescent powders, fructose and maltose powders, liquid sorbitol, lubricants, mannitol, sorbitol, and specialty binders/buffers. It also offers antacid actives, such as coblend suspension products, DC powders, aluminum hydroxide
dried gels, magnesium hydroxide pastes, magnesium hydroxide powders, and vaccine support products; and drug delivery systems and solutions. The company offers its products for application in solid dosage formulation, viscous
suspensions/blends, DC chewing gum, effervescent systems,
chewable/quick-dissolve tablets, and customized granulations. It sells its products through distributors in Americas, Europe, the Middle East, Africa, and the Asia
Pacific. The company also engages in the distribution of pharmaceutical, veterinary, nutraceutical, and food ingredients to customers in Australia. SPI Pharma, Inc. was formerly known as SPCA Barcroft. The company was founded in 1930 and is based in Wilmington, Delaware. It has facilities in Lewes and New
Castle, Delaware; Septemes, France; Grand Haven, Michigan; and Bengaluru, India.

Company name

AB MAURI MALAYSIA SDN. BHD.
Affiliation type

Sister Company
Country of business

Malaysia

 

Remarks on corporate affiliations and related companies
Other companies of the Associated British Foods Group should be considered affiliates of the Subject.

 

BANK AND MORTGAGES

 

Bank Details

 

Name of bank
National Australia Bank
Address

Australia

 

Comments
It is generally not the policy of local banks to provide credit status information to non related parties, however interested parties would be advised to consult first with the Subject if banker's references are required.

 

Mortgages

 

None reported.

 

 

Legal Filings

 

Bankruptcy filings
None reported.
Court judgements

None reported.

Tax liens
None reported.
Others

None reported.

 

FINANCIAL STATISTICS

 

Description

 

Financial statement source
Commercial Registry Filings
Financial statement date

31/08/13
Style of financial statement

Full audited

 

Currency of financial statement
Australia Dollar (AUD)
Exchange rate

1 USD = AUD 1.14 as of 16-10-2014

 

 

Concise Financial Data

Consolidation style

Non Consolidated

Non Consolidated

Group Consolidated

 

Currency

Australia Dollar (AUD)

Australia Dollar (AUD)

United Kingdom, Pound (GBP)

 

Date of financial year end

31/08/13

31/08/12

14/09/13

 

Length of financial accounts

12 months

12 months

12 months

 

Sales turnover / Revenue / Income

16,856,206.00

17,778,258.00

13,315,000,000.00

 

Gross profit

4,141,673.00

4,317,034.00

 

 

Profit / Loss before tax

1,842,232.00

2,000,520.00

876,000,000.00

 

Net income / loss

1,290,709.00

1,404,781.00

634,000,000.00

 

Non-current assets

253,403.00

315,969.00

6,921,000,000.00

 

Property, plant and equipment

42,408.00

47,328.00

4,552,000,000.00

 

Current assets

10,850,764.00

9,974,074.00

3,424,000,000.00

 

Inventories

3,283,803.00

3,790,078.00

1,581,000,000.00

 

Cash and cash equivalents

3,468,314.00

2,571,707.00

362,000,000.00

 

Accounts receivable

4,098,647.00

3,612,289.00

1,342,000,000.00

 

Total assets

11,104,167.00

10,290,043.00

10,345,000,000.00

 

Current liabilities

3,224,242.00

3,826,311.00

2,526,000,000.00

 

Non-current liabilities

10,461.00

18,977.00

1,322,000,000.00

 

Accounts payable

2,925,641.00

3,543,429.00

1,881,000,000.00

 

Total liabilities

3,234,703.00

3,845,288.00

3,848,000,000.00

 

Share equity

7,869,464.00

6,444,755.00

6,497,000,000.00

 

Retained earnings

7,723,464.00

6,432,755.00

5,486,000,000.00

 

Reserves

96,000.00

-38,000.00

 

 

Remarks

 

The non-consolidated financial information above relates to the Subject only.

The group’s consolidated financial information above relates to the Subject’s Intermediate Holding Company Associated British Foods PLC and all its subsidiaries which include the Subject.

 

 BUSINESS DETAILS

 

Operational Details

 

Main activities
The Subject engages in import & distribution of pharmaceutical, veterinary, nutraceutical and food ingredients products.

The Subject was formed as the regional office for SPI Pharma Inc. based in United States of America.

The Subject is a wholly owned subsidiary of SPI Pharma Inc. which is engaged in custom formulation solutions for pharmaceutical and nutraceutical manufacturers.

SPI Pharma, Inc. provides custom formulation solutions for pharmaceutical and neutriceutical, and animal health markets. The company offers excipients, including effervescent powders, fructose and maltose powders, liquid sorbitol, lubricants, mannitol, sorbitol, and specialty binders/buffers. It also offers antacid actives, such as coblend suspension products, DC powders, aluminum hydroxide dried gels, magnesium hydroxide pastes, magnesium hydroxide powders, and vaccine support products; and drug delivery systems and solutions.

It sells its products through distributors in Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company also engages in the distribution of pharmaceutical, veterinary, nutraceutical, and food ingredients to customers in Australia. SPI Pharma, Inc. was formerly known as SPCA Barcroft. The company was founded in 1930 and is based in Wilmington, Delaware. It has facilities in Lewes and New Castle, Delaware; Septemes, France; Grand Haven, Michigan; and Bengaluru, India.
Products and services

Pharmaceutical ingredients: Active Pharmaceutical Ingredient, Excipients, Drug Delivery System etc

Food Ingredients: Antioxidants, Bulking Agents – Maltodextrin, Dextrose, Colours – Natural & Artificial, Emulsifiers, Fibres, Flavours – Natural, Nature Identical & Artificial, Fruits and Vegetables Products, IQF, Puree, Juice Concentrates, Freeze Dried, Extracts., Hydrocollids, Preservatives-Natural & Synthetic, Proteins – Animal & Vegetable, Starches, Sweeteners – Natural & Synthetic, Vegetable Oils

Nutraceutical and functional ingredients: Amino Acids, Antioxidants, Bioflavonoids, Carbohydrates, Co Enzyme Q10, Dietary Fibres, Dietary Supplements, Extracts, Fat Substitutes, Fruit & Vegetable Products – IQF, Puree, Juice Concentrates, Freeze Dried, Extracts., Functional lipids, Joint Health Ingredients, Minerals, Plant & Herbal Extract, Prebiotics, Probiotics, Proteins – Vegetable and Animal, Sugar Substitutes, Sweeteners, Vitamins

Animal health ingredients: Amino Acids, Antioxidants, Emulsifiers, Nutritive oils – Vegetable and Marine Source, Proteins – Animal & Vegetable, Starches, Veterinary raw materials

 

 

Purchases

 

 

International
The Subject sources its product(s) / material(s) from countries in Asia, Europe and United States.

 

Sales

 

Local
The Subject sells its product(s) locally.

International
The Subject exports its product(s) to countries in Asia, Europe and United States.

 

Business Facilities and Assets

 

Premises
The Subject operates from the verified heading address consisting of a warehouse and an administrative office.

 

Branches
None reported.

 

 

SUMMARIZED COUNTRY RISK

 

Gross Domestic Products (GDP) and Economic Overview

 

Central bank
Reserve Bank of Australia
Reserve of foreign exchange and gold

US$ 46.714 billion
Gross domestic product (GDP)

US$ 1.586 trillion
Purchasing power parity (GPP)

954.296 billion of International dollars
GDP per capita (current prices)

US$ 68,916
GDP composition by sector

agriculture: 4%
industry: 25.6%
services: 70.4%
Inflation

2010: 2.8%
2011: 3.4%
2012: 2.7%
Unemployment rate

2010: 5.2%
2011: 5.1%
2012: 5.2%

Public debt (general Government gross debt as percentage (%) of GDP)
2010: 20.4%
2011: 22.9%
2012: 24%
Government bond ratings

Standard & Poor's: AAA
Moody's rating: Aaa
Moody's outlook: STA
Market value of publicly traded shares

US$1.198 trillion

 

 

Trade and Competitiveness Overview

 

Total exports
US$263.9 billion
Export commodities

Coal, iron ore, gold, meat, wool, alumina, wheat, machinery and transport equipment
Total imports

US$239.7 billion
Import commodities

Machinery and transport equipment, computers and office machines, telecommunication equipment and parts; crude oil and petroleum products
Best countries for doing business

10 out of 185 countries
Global competitiveness ranking

20 (ranking by country on a basis of 144, the first is the best)

Major export partners
China 27.4%, Japan 19.2%, South Korea 8.9%, India 5.8%
Major import partners

China 18.5%, US 11.4%, Japan 7.9%, Singapore 6.3%, Germany 4.7%
FDI inflows

2009: US$26,554 million
2010: US$35,556 million
2011: US$41,317 million
FDI outflows

2009: US$16,693 million
2010: US$12,791 million
2011: US$19,999 million

 

Country and Population Overview

 

Total population
22.68 million
Total area

7,692,024 km2
Capital

Canberra

Currency
Australian dollars (AUD)
Internet users as percentage (%) of total population

79%

 

PAYMENT OUTLOOK

 

Purchases Term

 

 

International
L/C, Telegraphic transfer, D/P, Credit 30-90 days

 

Sales Term

 

Local
Prepayment, Bank transfer, D/P, Credit 30-90 days

International
L/C, Telegraphic transfer, D/P, Credit 30-90 days

 

Trade Reference / Payment Behaviour

 

Comments
As local and international trade references were not supplied, the Subject's payment track record history cannot be appropriately determined but based on our research, payments are believed to be met without delay.

 

 

 

Investigation Note

 

Sources
Interviews and material provided by the Subject
Other official and local business sources

 

 

Attachments

 

Attachments
Financial statements

 

 


KEY FINANCIAL RATIOS

 

For financial year end

31/08/13

31/08/12

.

Profitability

.

.

.

Gross profit (loss) margin (%)

24.57

24.28

 

Pre-tax profit (loss) margin (%)

10.93

11.25

 

Net profit (loss) margin (%)

7.66

7.90

 

Earnings per share (currency based on financial statement)

25.81

28.10

 

Return on Invested Capital

.

.

.

Return on assets (%)

11.62

13.65

 

Return on equity (%)

16.40

21.80

 

Liquidity

.

.

.

Current ratio

3.37

2.61

 

Quick ratio

2.35

1.62

 

Cash ratio

0.32

0.26

 

Accounts receivable turnover ratio (times)

4.11

4.92

 

Accounts payable turnover ratio (times)

5.76

5.02

 

Collection period (days)

88.75

74.16

 

Payment period (days)

63.35

72.75

 

Inventory turnover ratio (times)

5.13

4.69

 

Inventory conversion period (days)

71.11

77.81

 

Asset Management

.

.

.

Fixed asset turnover ratio (times)

397.48

375.64

 

Asset turnover ratio (times)

1.52

1.73

 

Capital Structure and Solvency

.

.

.

Total debt to asset ratio (%)

29.13

37.37

 

Total debt to equity ratio (%)

41.10

59.67

 

Non-current debt to equity ratio (%)

0.13

0.29

 

 

 

 

 

 

 

ATTACHMENT

 

 

 

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.62

UK Pound

1

Rs.99.12

Euro

1

Rs.78.89

 

INFORMATION DETAILS

 

Analysis Done by :

SUM

 

 

Report Prepared by :

NIS

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.